These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6619136)

  • 1. Preliminary characterization of an endogenous inhibitor of [3H]estradiol binding in rat uterine nuclei.
    Markaverich BM; Roberts RR; Finney RW; Clark JH
    J Biol Chem; 1983 Oct; 258(19):11663-71. PubMed ID: 6619136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endogenous ligand for type II binding sites in normal and neoplastic tissues.
    Clark JH; Markaverich BM
    Adv Exp Med Biol; 1986; 196():305-15. PubMed ID: 3716924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
    Boctor AM; Band P; Grossman A
    Endocrinology; 1983 Aug; 113(2):453-62. PubMed ID: 6872936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of nuclear type II [(3)H]estradiol binding sites from the rat uterus: covalent labeling with [(3)H]luteolin.
    Markaverich BM; Shoulars K; Brown MA
    Steroids; 2001 Sep; 66(9):707-19. PubMed ID: 11546559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary characterization and partial purification of rat uterine nuclear type II Binding sites.
    Markaverich BM; Gregory RR
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1283-90. PubMed ID: 2059216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition.
    Markaverich BM; Roberts RR; Alejandro MA; Johnson GA; Middleditch BS; Clark JH
    J Steroid Biochem; 1988; 30(1-6):71-8. PubMed ID: 3386279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary assessment of luteolin as an affinity ligand for type II estrogen--binding sites in rat uterine nuclear extracts.
    Markaverich BM; Gregory RR
    Steroids; 1993 Jun; 58(6):268-74. PubMed ID: 8212072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor.
    Schoenberg DR; Clark JH
    Endocrinology; 1980 Jan; 106(1):56-60. PubMed ID: 7349972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
    Carlson RA; Gorski J
    Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of 3H-estradiol to the cytosol of rat pancreas and uterus: bound sites in pancreatic extracts do not translocate 3H-estradiol to nuclei suggesting a basic difference in mode of action.
    Boctor AM; Band P; Grossman A
    J Recept Res; 1981-1982; 2(5-6):453-63. PubMed ID: 7349314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the calf uterine estrogen receptor with acceptor sites in heterologous chicken target cell nuclei.
    de Boer W; Snippe L; Ab G; Gruber M
    J Steroid Biochem; 1986 Apr; 24(4):825-33. PubMed ID: 3702460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosome-associated estradiol-binding components in the uterus and their relationship to the translational capacity of uterine ribosomes.
    Labate ME; Whelly SM; Barker KL
    Endocrinology; 1986 Jul; 119(1):140-51. PubMed ID: 3720662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine type II estrogen-binding sites are not of eosinophil origin.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    J Biol Chem; 1986 Jan; 261(1):142-6. PubMed ID: 3941067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils as the source of uterine nuclear type II estrogen binding sites.
    Lyttle CR; Medlock KL; Sheehan DM
    J Biol Chem; 1984 Mar; 259(5):2697-700. PubMed ID: 6698988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.